LENSAR, Inc. Files 8-K on Shareholder Nominations

TL;DR

LENSAR filed an 8-K on Oct 15th for shareholder nominations - board shakeup incoming?

AI Summary

LENSAR, Inc. filed an 8-K on October 21, 2025, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11 and other events. The report covers activities as of October 15, 2025. The company, incorporated in Delaware, is based in Orlando, Florida.

Why It Matters

This filing indicates potential changes in the company's board composition or strategic direction due to shareholder nominations, which could impact future governance and operations.

Risk Assessment

Risk Level: medium — Shareholder nominations can signal activism or dissatisfaction, potentially leading to changes in management or strategy.

Key Numbers

• 001-39473 — SEC File Number (Identifies the company's filing with the SEC.)
• 32-0125724 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• LENSAR, Inc. (company) — Registrant
• October 15, 2025 (date) — Date of earliest event reported
• October 21, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Orlando, Florida (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common stock, par value $0.01 per share LNSR The Nasdaq Stock Mar

Filing Documents

• lnsr-20251015.htm (8-K) — 52KB
• 0001193125-25-245196.txt ( ) — 161KB
• lnsr-20251015.xsd (EX-101.SCH) — 25KB
• lnsr-20251015_htm.xml (XML) — 5KB

08 Shareholder Director Nominations

Item 5.08 Shareholder Director Nominations To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

01 Other Events

Item 8.01 Other Events. LENSAR, Inc. (the "Company") announced today that the Company's 2025 annual meeting of stockholders (the "2025 Annual Meeting") has been scheduled for December 18, 2025 and is to be held virtually. All holders of record of common stock outstanding as of the close of business on October 24, 2025 will be entitled to vote at the 2025 Annual Meeting. The time and website address for the 2025 Annual Meeting will be set forth in the Company's definitive proxy statement for the 2025 Annual Meeting. The 2025 Annual Meeting does not relate to the proposed merger transaction with Alcon Research, LLC (the "Merger") and will only take place in the event that the Merger is not completed prior to the 2025 Annual Meeting. Should the Merger be completed before the 2025 Annual Meeting, the Company will be a wholly owned subsidiary of Alcon Research, LLC and, accordingly, such 2025 Annual Meeting will not occur as set forth in the definitive proxy statement, and any director candidates or stockholder proposals submitted will not be considered by the Company's stockholders. As the 2025 Annual Meeting is being held more than 30 days after the anniversary of the Company's 2024 annual meeting of stockholders (the "2024 Annual Meeting") under Rule 14a-5(f) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and by more than 60 days after the 2024 Annual Meeting under the Company's Amended and Restated Bylaws (the "Bylaws"), the Company is hereby providing notice of the below revised deadlines for qualified stockholder proposals and stockholder nominations. In order for a stockholder proposal for the 2025 Annual Meeting to be eligible for inclusion in the Company's proxy statement pursuant to Rule 14a-8 of the Exchange Act, the Company must receive the proposal and supporting statements at its principal executive office no later than the close of business on October 31, 2025. Stockholder proposals and director nominations brought unde

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Current Report that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Merger, including the expected closing timing thereof. In some cases, you can identify forward-looking statements by terms such as "aim," "anticipate," "approach," "believe," "contemplate," "could," "estimate," "expect," "goal," "intend," "look," "may," "mission," "plan," "possible," "potential," "predict," "project," "pursue," "should," "target," "will," "would," or the negative thereof and similar words and expressions. Forward-looking statements are based on management's current expectations, beliefs and assumptions and on information currently available to us. Such statements are subject to a number of known and unknown risks, uncertainties and assumptions. The following factors could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: (i) the proposed Merger may not be completed in a timely manner or at all, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the Company or the expected benefits of the proposed Merger; (ii) the failure to realize the anticipated benefits of the proposed Merger; (iii) the possibility that competing offers or acquisition proposals for the Company will be made; (iv) the possibility that any or all of the various conditions to the consummation of the Merger may not be satisfied or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals); (v) t

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LENSAR, Inc. Date: October 21, 2025 By: /s/ Nicholas T. Curtis Name: Title: Nicholas T. Curtis Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR